Clarivate to Sell Life Sciences & Healthcare Business for $600 Million
Clarivate (CLVT) has agreed to sell its Life Sciences & Healthcare segment to Altaris in a deal valued at approximately $600 million. The transaction includes $500 million in cash, a $75 million seller note, and $25 million in deferred cash tied to transition services. Proceeds will be used for debt reduction.